LYBE SCIENTIFIC AS
Operating
Å utvikle og tilby ulike løsninger for prøvepreparering og analyse
innenfor diagnostikkformål.
Å utvikle og tilby ulike løsninger innenfor sample prep, herunder
nukleinsyreekstraksjonsløsninger samt analysemetoder for
diagnostikkformål.
Organization
- CEO
- TS
- Chairman of the board
- MW
Mårten Wigstøl1960
- Years since formation
- 5 years
- since Mar 3, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 5
Ownership
- Number of shares and share classes
- 151,329
- 1 share class
- Total number of shareholders
- 15
- 9 companies, 6 persons
Financials
- Total operating income 2025
- 3,550,849
- NOK
- Annual total result 2025
- -294,559
- NOK
Last update: Jul 28, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
TS | Managing Director/CEO | 10.63 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
MW 1960 | Chairman | 4.87 % indirectly |
SB | Board Member | 7.54 % indirectly |
GØ 1981 | Board Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
TS | Managing Director/CEO | 10.63 % indirectly |
MB 1965 | - | 9.05 % directly |
SB | Board Member | 7.54 % indirectly |
ØG 1980 | - | 5.58 % indirectly |
MW 1960 | Chairman | 4.87 % indirectly |
LA | - | 4.13 % indirectly |
SE | - | 4.1 % directly |
PA 1971 | - | 3.77 % directly |
VO 1981 | - | 2.26 % directly |
AS 1991 | - | 2.26 % directly |
Last update: Aug 25, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 28,000 | 18.5 % | |
| Ordinary shares | 16,667 | 11.01 % | |
| Ordinary shares | 16,086 | 10.63 % | |
MB 1965 | Ordinary shares | 13,694 | 9.05 % |
| Ordinary shares | 13,000 | 8.59 % | |
| Ordinary shares | 11,412 | 7.54 % | |
| Ordinary shares | 8,333 | 5.51 % | |
T Closed | Ordinary shares | 8,333 | 5.51 % |
| Ordinary shares | 7,373 | 4.87 % | |
| Ordinary shares | 6,250 | 4.13 % | |
SE | Ordinary shares | 6,206 | 4.1 % |
PA 1971 | Ordinary shares | 5,706 | 3.77 % |
AS 1991 | Ordinary shares | 3,423 | 2.26 % |
LH 1975 | Ordinary shares | 3,423 | 2.26 % |
VO 1981 | Ordinary shares | 3,423 | 2.26 % |
Shares owned by the LYBE SCIENTIFIC AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 28,000 | 18.5 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 3,550,849 | 4,937,610 | 2,147,701 | 6,228,552 | 14,976,818 |
Annual Total Result | -294,559 | 87,041 | -2,559,171 | -709,976 | 2,500,125 |
Total assets | 0 | 17,765,313 | 12,891,592 | 10,915,258 | 5,313,476 |
Total liabilities | 0 | 8,923,153 | 7,690,950 | 9,015,109 | 2,703,351 |
Total equity | 0 | 8,842,159 | 5,200,642 | 1,900,149 | 2,610,125 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 3,550,849 | 4,937,610 | 2,147,701 | 6,228,552 | 14,976,818 |
Total operating costs | 3,322,405 | 4,435,287 | 4,502,825 | 7,026,094 | 11,765,775 |
Operating result | 228,444 | 502,322 | -2,355,124 | -797,542 | 3,211,043 |
Financial income/costs | -523,002 | -415,281 | -27,526 | -103,190 | -5,611 |
Profit before tax | -294,559 | 87,041 | -2,382,650 | -900,732 | 3,205,432 |
Total tax & extraordinary income/cost | 0 | 0 | 176,521 | -190,756 | 705,307 |
Annual Total Result | -294,559 | 87,041 | -2,559,171 | -709,976 | 2,500,125 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 10,156,386 | 5,803,417 | 2,978,561 | 831,160 |
Total current assets | 0 | 7,608,926 | 7,088,175 | 7,936,697 | 4,482,316 |
Total assets | 0 | 17,765,313 | 12,891,592 | 10,915,258 | 5,313,476 |
Short term debt | 0 | 5,256,489 | 4,140,828 | 4,438,634 | 1,989,116 |
Long term debt | 0 | 3,666,664 | 3,550,122 | 4,576,475 | 714,235 |
Total liabilities | 0 | 8,923,153 | 7,690,950 | 9,015,109 | 2,703,351 |
Contributed capital | 0 | 8,931,889 | 5,377,413 | 110,000 | 110,000 |
Retained earnings | 0 | -89,730 | -176,771 | 1,790,149 | 2,500,125 |
Total equity | 0 | 8,842,159 | 5,200,642 | 1,900,149 | 2,610,125 |
Total equity and liabilities | 0 | 17,765,313 | 12,891,592 | 10,915,258 | 5,313,476 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises